PowerShares Dynamic Biotech & Genome ETF
(NYSE ARCA: PBE)
AdChoices
47.24
-0.13
-0.27%
:

Open

47.17

Net Assets

389.05M

Day's Range

46.66-47.58

52 week range

33.96-48.12

Category

Health

Vol (3-Month Avg.)

48.85k

Yield

0.60%

Morningstar Risk

Above Average

AdChoices
Performance
Returns %
Key statistics
  • Composition
  • Performance
  • Top Holdings
  • Key Statistics
Composition
Top Equity Sector Holding
Equity Investment Style
The two dimensions of the Fund Style box measure the average size of companies that have been in the ETF, from the top to bottom, and the average valuation characteristics of the ETF's past stock holdings, from left to right.

PERFORMANCE

  • Total Return %

  • 1 Day

  • 1 Week

  • 1 Month

  • 3 Months

  • 1 Year

  • 3 Years

  • 5 Years

    • PBE

    • 2.40

    • 8.35

    • 2.49

    • 11.78

    • 38.72

    • 33.75

    • 23.78

    • Category(Health)

    • 2.26

    • 5.05

    • -1.00

    • 5.52

    • 26.15

    • 28.26

    • 22.49

    • Rank in Category

    • 43

    • 15

    • 1

    • 15

    • 5

    • 23

    • 36

    MORNINGSTAR RATING

    • Years

    • Return

    • Risk

    • Rating

      • 3 Years

      • Above Average

      • Above Average

      • ★★★
      • 5 Years

      • Average

      • Above Average

      • ★★★
      • 10 Years

      • -

      • -

      • -

      • Overall

      • Average

      • Above Average

      • ★★★

      TOP HOLDINGS

      • Name

      • % Portfolio Weight

      • Shares Held

      • Change

        • Sigma-Aldrich Corp

        • 6.75

        • 193,912

        • 0

        • Regeneron Pharmaceuticals Inc

        • 5.08

        • 57,534

        • 0

        • Alexion Pharmaceuticals Inc

        • 5.03

        • 119,126

        • 0

        • Amgen Inc

        • 4.89

        • 144,690

        • 0

        • Gilead Sciences Inc

        • 4.70

        • 187,459

        • 0

        • Illumina Inc

        • 4.66

        • 112,438

        • 0

        • Biogen Idec Inc

        • 4.61

        • 58,789

        • 0

        • Pharmacyclics Inc

        • 4.58

        • 162,126

        • 0

        • Repligen Corp

        • 3.33

        • 577,129

        • 0

        • Insys Therapeutics Inc

        • 3.09

        • 311,441

        • 0

        CATEGORY

        • Name

        • PBE

        • Category

          • Avg. Market Cap USD (M)

          • 6,512.31

          • 27,214.31

          • Expense Ratio

          • 0.59%

          • 0.44%

          • Net Assets

          • 389.05M

          • 1.06B

          • Price/Prospective Earnings

          • 28.03

          • 21.83

          • Price/Book

          • 5.24

          • 4.82

          • Price/Sales

          • 5.75

          • 3.25

          • Price/Cash Flow

          • 13.44

          • 19.29

          • Dividend Yield

          • 0.37%

          • 0.37

          Profile

          Name of Issuer

          PowerShares

          Expenses

          0.59%

          The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the Dynamic Biotechnology & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

          Inception

          6/23/2005